D. Medical IPO Newsletter
-
Cyient DLM trading 183% higher than IPO price. Is it still a 'buy'? Here's what LKP Securities says
20 Jun 2024 13:06 GMT
… shares have jumped from ₹265 (IPO price) apiece to the current … aerospace and defence (A&D), medical technology, and industrial sectors. The …
-
Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
25 Sep 2024 16:23 GMT
… ; commented Anjali T. Owens, M.D., Medical Director, Center for Inherited Cardiac … is recovering from its post-IPO blahs and appears to be …
-
Carmell Therapeutics Merger With Alpha Healthcare Acquisition Corp III (Nasdaq: ALPA) July 6, 2023 - Form 8-K
07 Jul 2023 01:20 GMT
… Raised $500+ million via IPO+PIPE as CEO since 2017 … C. CAROLYN THIEDKE, M.D., Medical University of South Carolina, … prospectus relating to its initial public offering, dated July 27, … prospectus relating to its initial public offering, dated July 27, 2021 …
-
Singapore’s Healthcare Industry: Gateway to ASEAN’s Healthcare Market
18 Jul 2022 09:15 GMT
… Intellectual Property Office of Singapore (IPOS), a government agency under the … D
Class B, C, and D medical devices are required to be …
-
Vitro Biopharma Inc. July 31st 2021; 3rd Quarter ended Financial Results of Operations and Shareholder Letter.
10 Oct 2021 19:19 GMT
… Dr. Chad C. Prodromos M.D.; Medical Director and CEO the Prodromos … public with an institutional sponsored IPO on the NASDQ or New … investment banks about a Vitro IPO and listing on the NASDQ …
-
16 Marijuana 4/20 Facts That Show How Far the Cannabis Movement Has Come
19 Apr 2019 22:49 GMT
… Utah have recently OK'd medical marijuana for select ailments. … Marijuana stocks are going the initial public offering route on major U.S … weed stocks have gone the initial public offering (IPO) route on reputable U. … 17 in July when it IPO'd on the …
-
Kymera Reports Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
13 Oct 2020 15:16 GMT
… ;or surgery. With a recent IPO and concurrent private placement to … placebo. Dr. Steven Nathan M.D., medical director, Advanced Lung Disease …
-
Medovex Corporation Announces First DenerveX(TM) System Pre-Production Use in Live Tissue Model
14 Jan 2016 16:46 GMT
ATLANTA, GA -- (Marketwired) -- 01/14/16 -- Medovex Corp. (NASDAQ: MDVX), a developer of medical technology products, today announced that its DenerveX™ System has been used for the first time in a live tissue model using the final pre-production …